MP58-16 SGLT2-INHIBITOR USAGE AND INCIDENCE OF FOURNIER′S GANGRENE

2020 
INTRODUCTION AND OBJECTIVE:In May 2019, the Food and Drug Administration (FDA) issued a Black Box Warning against sodium-glucose cotransporter-2 inhibitor (SGLT2) antihyperglycemic medications, cit...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []